These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20723183)

  • 1. Challenges in HIV and visceral Leishmania co-infection: future research directions.
    Ejara ED; Lynen L; Boelaert M; Van Griensven J
    Trop Med Int Health; 2010 Oct; 15(10):1266-7. PubMed ID: 20723183
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous leishmaniasis associated with visceral leishmaniasis in a case of acquired immunodeficiency syndrome (AIDS).
    Pourahmad M; Hooshmand F; Rahiminejad M
    Int J Dermatol; 2009 Jan; 48(1):59-61. PubMed ID: 19126052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unwelcome synergy: leishmaniasis and HIV.
    Colasanti J; Altamirano J; Espinoza L
    Am J Med; 2013 Feb; 126(2):114-6. PubMed ID: 23331437
    [No Abstract]   [Full Text] [Related]  

  • 5. Cutaneous manifestations of visceral leishmaniasis resistant to liposomal amphotericin B in an HIV-positive patient.
    Alsina-Gibert M; López-Lerma I; Martinez-Chamorro E; Herrero-Mateu C
    Arch Dermatol; 2006 Jun; 142(6):787-9. PubMed ID: 16785393
    [No Abstract]   [Full Text] [Related]  

  • 6. [Visceral leishmaniasis in patients with HIV infection].
    Ribera E; Cucurull E; Ocaña I; Vallespí T; Gasser I; Juste C
    Enferm Infecc Microbiol Clin; 1995 Feb; 13(2):73-9. PubMed ID: 7711130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of splenectomy in HIV-infected patients with relapsing visceral leishmaniasis.
    Troya J; Casquero A; Muñiz G; Fernández-Guerrero ML; Górgolas M
    Parasitology; 2007 May; 134(Pt 5):621-4. PubMed ID: 17156583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 9. [Visceral leishmaniasis and HIV infection in the HAART era].
    Marques N; Cabral S; Sá R; Coelho F; Oliveira J; Saraiva da Cunha JG; Meliço Silvestre A
    Acta Med Port; 2007; 20(4):291-8. PubMed ID: 18198072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral leishmaniasis due to Leishmania donovani in a patient with advanced HIV infection.
    Hume SC; Aboltins CA; Thursky KA; Daffy JR; Stanley PA
    Med J Aust; 2010 Apr; 192(8):474-5. PubMed ID: 20402615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-associated visceral leishmaniasis.
    Pintado V; López-Vélez R
    Clin Microbiol Infect; 2001 Jun; 7(6):291-300. PubMed ID: 11442562
    [No Abstract]   [Full Text] [Related]  

  • 12. [A malabsorption syndrome, gastrointestinal leishmaniasis and HIV infection].
    Alguacil GF; Moreno J; Ortolano A; Hallal H
    Gastroenterol Hepatol; 1997; 20(7):386. PubMed ID: 9377243
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia.
    Hurissa Z; Gebre-Silassie S; Hailu W; Tefera T; Lalloo DG; Cuevas LE; Hailu A
    Trop Med Int Health; 2010 Jul; 15(7):848-55. PubMed ID: 20487426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine for Indian visceral leishmaniasis.
    Agarwal PK
    N Engl J Med; 2003 Feb; 348(9):857-8; author reply 857-8. PubMed ID: 12606744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Leishmaniasis. Basic principles, clinical aspects, diagnosis and therapy].
    Burbach G; May J; Harms G; Bienzle U
    Dtsch Med Wochenschr; 1999 Jan; 124(4):88-93. PubMed ID: 10071606
    [No Abstract]   [Full Text] [Related]  

  • 16. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will earlier diagnosis of HIV infection in late presenters reduce the frequency of serious opportunistic infections?
    Scourfield A; Jackson A; Nelson M
    HIV Med; 2011 Aug; 12(7):449-50. PubMed ID: 21729231
    [No Abstract]   [Full Text] [Related]  

  • 18. Engima of therapeutic failure in visceral leishmaniasis.
    Arya SC
    J Assoc Physicians India; 1993 Mar; 41(3):155-8. PubMed ID: 8226600
    [No Abstract]   [Full Text] [Related]  

  • 19. Uveitis secondary to leishmaniasis immune reconstitution syndrome in a HIV-positive patient.
    Davies O; Allen F; Gruener AM; Simons R; Graham EM; Larbalestier N
    Int J STD AIDS; 2016 Jun; 27(7):598-600. PubMed ID: 26002317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis.
    Vase MØ; Hellberg YK; Larsen CS; Petersen E; Schaumburg H; Bendix K; Ravel C; Bastien P; Christensen M; d'Amore F
    Acta Haematol; 2012; 128(1):20-2. PubMed ID: 22572474
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.